关注
Joseph Wrin
Joseph Wrin
PhD candidate University of Adelaide, Basil Hetzel Institute
在 adelaide.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab …
TJ Price, JE Hardingham, CK Lee, A Weickhardt, AR Townsend, JW Wrin, ...
Journal of Clinical Oncology 29 (19), 2675-2682, 2011
2622011
Pharmacological blockade of aquaporin-1 water channel by AqB013 restricts migration and invasiveness of colon cancer cells and prevents endothelial tube formation in vitro
HS Dorward, A Du, MA Bruhn, J Wrin, JV Pei, A Evdokiou, TJ Price, ...
Journal of Experimental & Clinical Cancer Research 35, 1-9, 2016
812016
Dissecting the biology of menstrual cycle-associated breast cancer risk
V Atashgaran, J Wrin, SC Barry, P Dasari, WV Ingman
Frontiers in oncology 6, 267, 2016
682016
Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab
TJ Price, JE Hardingham, CK Lee, AR Townsend, JW Wrin, K Wilson, ...
Cancer medicine 2 (3), 277-285, 2013
422013
Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in …
TJ Price, MA Bruhn, CK Lee, JE Hardingham, AR Townsend, KP Mann, ...
British journal of cancer 112 (6), 963-970, 2015
402015
Nanostructured polystyrene well plates allow unbiased high-throughput characterization of circulating tumor cells
Y Wan, M Winter, B Delalat, JE Hardingham, PK Grover, J Wrin, ...
ACS applied materials & interfaces 6 (23), 20828-20836, 2014
342014
Monoclonal antibodies that bind to and neutralize dimeric but not monomeric human M-CSF and methods of use thereof for detection of dimeric M-CSF
RF Halenbeck, KE Koths, JW Wrin
US Patent 5,491,065, 1996
211996
High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients …
SS Kumar, Y Tomita, J Wrin, M Bruhn, A Swalling, M Mohammed, TJ Price, ...
Clinical and Translational Oncology 19, 718-726, 2017
182017
Discordance in 21-gene recurrence scores between paired breast cancer samples is inversely associated with patient age
SM Bernhardt, P Dasari, J Wrin, W Raymond, S Edwards, D Walsh, ...
Breast Cancer Research 22, 1-10, 2020
152020
Identification of a cell surface protein with a role in stimulating human keratinocyte proliferation, expressed during development and carcinogenesis
P Kaur, S Paton, J Furze, J Wrin, S Olsen, J Danks, J Scurry
Journal of investigative dermatology 109 (2), 194-199, 1997
121997
Building performance dashboards and balanced scorecards with SQL server reporting services
C Price, A Jorgensen, D Knight
John Wiley & Sons, 2013
102013
BRAF V600E Mutation Detection Using High Resolution Probe Melting Analysis, Polymerase Chain Reaction. Hernandez-Rodriguez P (Eds.). ISBN: 978-953-51-0612-8
JE Hardingham, A Chua, JW Wrin, A Shivasami, I Kanter, NC Tebbutt, ...
Tech, Retrieved March, 2015
52015
BRAF V600E Mutation Detection Using High Resolution Probe Melting Analysis
JE Hardingham, A Chua, JW Wrin, A Shivasami, I Kanter, NC Tebbutt, ...
Polymerase Chain Reaction, 2012
12012
The Effect Of Age And Menstrual Cycling On Gene Expression Profiling Tests
SM Bernhardt, P Dasari, J Wrin, W Raymond, S Edwards, D Walsh, ...
The Breast 68, 240-241, 2023
2023
Development and Evaluation of Mouse Monoclonal Antibodies Against Human C1q
JW Wrin
2022
The effect of aquaporin-5 knockdown on HT29 colon cancer cell proliferation and migration
Y Tomita, H Dorward, J Wrin, RJ Vary, ML De Ieso, AJ Yool, J Price, ...
ANNALS OF ONCOLOGY 26, 4-4, 2015
2015
14P The effect of aquaporin-5 knockdown on HT29 colon cancer cell proliferation and migration
Y Tomita, H Dorward, J Wrin, RJ Vary, ML De Ieso, AJ Yool, TJ Price, ...
Annals of Oncology 26, ix1, 2015
2015
Basic science
Y Tomita, H Dorward, J Wrin, RJ Vary, ML De Ieso, AJ Yool, TJ Price, ...
2015
Pten and Advanced Colorectal Cancer (CRC): Analysis from the Phase III Agitg Max Trial of Capecitabine Alone or in Combination with Bevacizumab+/-Mitomycin C
T Price, J Hardingham, C Lee, A Townsend, J Wrin, K Wilson, ...
Annals of Oncology 23, ix182, 2012
2012
IMPACT OF KRAS AND BRAF GENE MUTATION STATUS ON OUTCOMES FROM THE PHASE III AGITG MAX TRIAL OF CAPECITABINE (C) ALONE OR IN COMBINATION WITH BEVACIZUMAB (B)+/-MITOMYCIN C (M …
TJ Price, J Hardingham, C Lee, A Weickhardt, A Townsend, JW Wrin, ...
ANNALS OF ONCOLOGY 21, 198-198, 2010
2010
系统目前无法执行此操作,请稍后再试。
文章 1–20